Physician

Mark E Patron, MD

According to 2025 Medicare claims, Mark Patron, MD (NPI: 1215134176) practices ophthalmology in the Denver-Aurora-Centennial, CO market, with the plurality of this provider's patient population coming from Denver, CO. This provider's primary affiliated billing organization is MILE HIGH RETINA, PLLC (NPI: 1235728189; TIN: 850526245) and primary practice location at 80246-2281.

Patron's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 382 traditional Medicare patients, billed 45,440 HCPCS/CPT codes, and received $1,494,332 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 66 prescription claims across 44 beneficiaries totaling $2,405 in drug costs, led by Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha). Open Payments data shows 4 records totaling $92. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $710,674 and ending at $1,494,332. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $6,414 and ending at $2,405. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$747K$1.5M2015 Medicare payment: $710,674 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $806,435 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $886,083 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,143,561 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,135,345 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $158,499 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $323,812 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $684,348 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $848,651 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,494,332 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155406,319$710,674
20166036,698$806,435
20176266,894$886,083
20187047,505$1,143,561
20196447,367$1,135,345
20202831,279$158,499
20212502,468$323,812
20223755,168$684,348
20233678,921$848,651
202438245,440$1,494,332

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$6.1K$12K2015 Drug cost: $6,414 (USD; Tot_Drug_Cst)2016 Drug cost: $8,035 (USD; Tot_Drug_Cst)2017 Drug cost: $8,700 (USD; Tot_Drug_Cst)2018 Drug cost: $8,439 (USD; Tot_Drug_Cst)2019 Drug cost: $12,287 (USD; Tot_Drug_Cst)2020 Drug cost: $3,548 (USD; Tot_Drug_Cst)2021 Drug cost: $1,178 (USD; Tot_Drug_Cst)2022 Drug cost: $5,049 (USD; Tot_Drug_Cst)2023 Drug cost: $3,304 (USD; Tot_Drug_Cst)2024 Drug cost: $2,405 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201556115$6,414
20164696$8,035
201754127$8,700
201866144$8,439
201963161$12,287
20202047$3,548
20212034$1,178
20225185$5,049
20233166$3,304
20244466$2,405

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system116116$109
67028Injection of drug into eye152800$94
92014Established patient complete exam of visual system314548$94
92134Imaging of retina3791,188$31
92201Extended exam of the back part of the eye with retinal drawing253405$18

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha29566$326

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$92Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mark E. Patron, MD?

Tedicare shows public-source Medicare data for Mark E. Patron, MD (NPI 1215134176), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark E. Patron, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark E. Patron, MD?

Mark E. Patron, MD is linked to MILE HIGH RETINA, PLLC (billing NPI 1235728189) in the available physician profile data.

Does Mark E. Patron, MD have Open Payments data?

Mark E. Patron, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.